ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization

Sharmila Dorbala¹, Yukio Ando², Sabahat Bokhari³, Angela Dispenzieri⁴, Rodney H Falk⁵, Victor A Ferrari⁶, Marianna Fontana⁷, Olivier Gheysens⁸, Julian D Gillmore⁷, Andor W J M Glaudemans⁹, Mazen A Hanna¹⁰, Bouke P C Hazenberg¹¹, Arnt V Kristen¹², Raymond Y Kwong⁵, Mathew S Maurer³, Giampaolo Merlini^{13

14}, Edward J Miller¹⁵, James C Moon⁷, Venkatesh L Murthy¹⁶, C Cristina Quarta⁷, Claudio Rapezzi¹⁷, Frederick L Ruberg¹⁸, Sanjiv J Shah¹⁹, Riemer H J A Slart⁹, Hein J Verberne²⁰, Jamieson M Bourque²¹

Affiliations

¹ Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. sdorbala@bwh.harvard.edu.
² Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
³ Columbia University Medical Center, Columbia University Medical Center/New York Presbyterian Hospital, Columbia University, New York, NY, USA.
⁴ Divisions of Hematology and Cardiovascular Diseases, Department of Radiology, Division of Nuclear Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
⁵ Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
⁶ Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁷ Division of Medicine, National Amyloidosis Centre, University College London, London, United Kingdom.
⁸ Nuclear Medicine and Molecular Imaging, University Hospitals Leuven, Leuven, Belgium.
⁹ Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
¹⁰ Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
¹¹ Department of Rheumatology & Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
¹² Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
¹³ Amyloidosis Research and Treatment Center, Foundation Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.
¹⁴ Department of Molecular Medicine, University of Pavia, Pavia, Italy.
¹⁵ Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.
¹⁶ Frankel Cardiovascular Center, Michigan Medicine, Ann Arbor, MI, USA.
¹⁷ Cardiology Unit, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater-University of Bologna, Bologna, Italy.
¹⁸ Amyloidosis Center and Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
¹⁹ Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
²⁰ Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
²¹ Cardiovascular Imaging Center, Departments of Medicine and Radiology, University of Virginia, Charlottesville, VA, USA.

PMID: 31468377
DOI: 10.1007/s12350-019-01761-5

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization

Sharmila Dorbala et al. J Nucl Cardiol. 2020 Apr.

. 2020 Apr;27(2):659-673.

doi: 10.1007/s12350-019-01761-5.

Authors

Affiliations

¹ Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. sdorbala@bwh.harvard.edu.
² Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
³ Columbia University Medical Center, Columbia University Medical Center/New York Presbyterian Hospital, Columbia University, New York, NY, USA.
⁴ Divisions of Hematology and Cardiovascular Diseases, Department of Radiology, Division of Nuclear Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
⁵ Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
⁶ Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁷ Division of Medicine, National Amyloidosis Centre, University College London, London, United Kingdom.
⁸ Nuclear Medicine and Molecular Imaging, University Hospitals Leuven, Leuven, Belgium.
⁹ Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
¹⁰ Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
¹¹ Department of Rheumatology & Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
¹² Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
¹³ Amyloidosis Research and Treatment Center, Foundation Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.
¹⁴ Department of Molecular Medicine, University of Pavia, Pavia, Italy.
¹⁵ Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.
¹⁶ Frankel Cardiovascular Center, Michigan Medicine, Ann Arbor, MI, USA.
¹⁷ Cardiology Unit, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater-University of Bologna, Bologna, Italy.
¹⁸ Amyloidosis Center and Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
¹⁹ Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
²⁰ Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
²¹ Cardiovascular Imaging Center, Departments of Medicine and Radiology, University of Virginia, Charlottesville, VA, USA.

PMID: 31468377
DOI: 10.1007/s12350-019-01761-5

Erratum in

Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.
Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. Dorbala S, et al. J Nucl Cardiol. 2021 Aug;28(4):1763-1767. doi: 10.1007/s12350-021-02712-9. J Nucl Cardiol. 2021. PMID: 34279803 No abstract available.

Abstract

Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.

Keywords: Appropriate use; Cardiac amyloidosis; Diagnosis; Expert consensus; Multimodality.

PubMed Disclaimer

References

1. Circulation. 2016 Jun 14;133(24):2404-12 - PubMed
1. Eur Heart J. 2017 Oct 7;38(38):2879-2887 - PubMed
1. Circ Cardiovasc Imaging. 2012 Jul;5(4):500-8 - PubMed
1. Blood. 2018 Jan 11;131(2):163-173 - PubMed
1. J Clin Oncol. 2004 Sep 15;22(18):3751-7 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

FS/18/21/33447/BHF_/British Heart Foundation/United Kingdom

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Springer
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization

Affiliations

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization

Authors

Affiliations

Erratum in

Abstract

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical